Safety of the Herpes Zoster Subunit Vaccine in Lupus

Clinical trial NCT05559671 · RECRUITING

Trial details

NCT number: NCT05559671
Sponsor: NYU Langone Health
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2023-12-21
Primary completion: 2027-07-31
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.